Horizon Pharmaceutical LLC

( )
RPTP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.36%33.330.9%$1128.80m
JNJJohnson & Johnson -0.59%142.420.7%$1055.48m
BMYBristol-Myers Squibb Co. -0.02%58.111.0%$945.55m
MRKMerck & Co., Inc. -0.91%76.000.6%$793.75m
ABBVAbbVie, Inc. -1.29%98.001.9%$757.48m
LLYEli Lilly & Co. -1.60%166.421.1%$674.43m
AZNAstraZeneca Plc 0.80%54.411.2%$289.75m
RPRXRoyalty Pharma Plc 0.71%48.360.1%$217.04m
NVSNovartis AG -0.86%87.360.2%$145.69m
RGENRepligen Corp. 2.71%128.677.1%$119.15m
GSKGlaxoSmithKline Plc -0.96%40.340.2%$111.05m
NVONovo Nordisk A/S -0.43%65.600.1%$93.32m
RETAReata Pharmaceuticals, Inc. -1.19%156.123.4%$80.52m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -2.71%75.840.0%$71.05m
SNYSanofi -0.14%50.480.2%$68.16m

Company Profile

Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA.